Serum Transthyretin in the Management of TTR Amyloidosis

Justin L. Grodin, MD, MPH
Assistant Professor of Medicine
UT Southwestern Medical Center
Dallas, TX
Justin L. Grodin, MD, MPH, Assistant Professor of Medicine, UT Southwestern Medical Center, Dallas, TX, explains the current and potentially future utilities of serum transthyretin (sTTR) as a biomarker in the management of transthyretin amyloidosis.

Related Items

Subscribe to Amyloidosis News

Stay up to date with Amyloidosis News & updates by subscribing to receive the free AMN e‑Newsletter.

I'd like to receive: